Sandoz offers generic Remodulin for subcutaneous administration 

The introduction of the RG 3-ml Medication Cartridge has enabled subcutaneous administration of Sandoz's treprostinil injection for the first time.
Levy

Sandoz is offering treprostinil injection for subcutaneous administration to treat patients diagnosed with pulmonary arterial hypertension.

Sandoz treprostinil injection was the first generic of United Therapeutics’ Remodulin. 

Both options for intravenous and subcutaneous administration of Sandoz generic Treprostinil Injection now are available at the same specialty pharmacy that dispenses the brand-name medicine, and commercialized with Liquidia through a collaboration agreement. Liquidia had previously announced the FDA’s clearance of the use of a new cartridge with the Smiths Medical’s CADD-MS 3 pump, which has been used for the SC administration of Remodulin for more than 10 years.

“The FDA clearance of a path to bring additional new cartridges required for subcutaneous administration of this medicine means another option for patients who need access to this life-enhancing pulmonary arterial hypertension medicine,” said Sandoz president Keren Haruvi. “Sandoz has a strong track record for manufacturing high-quality generic medicines and supplying them reliably to the patients who need them.”

Since commercial launch two years ago, Sandoz treprostinil injection has only been used for intravenous administration. The cartridges required to operate the CADD-MS 3 pump, were not available to patients using generic treprostinil injection due to restrictions imposed by other companies. The introduction of the RG 3ml Medication Cartridge has enabled the subcutaneous administration of Sandoz's treprostinil injection for the first time.

Scott Moomaw, Liquidia’s senior vice president of commercial, said: “We are excited to provide a new option in the parenteral use of treprostinil injection. Patients who need and depend on subcutaneous administered treprostinil will now, for the first time, have access to a lower cost generic treprostinil. Through our agreement with Sandoz, we will continue to provide the same level of high-touch support and services to our patients, but at a lower cost compared to the branded product.”

X
This ad will auto-close in 10 seconds